Yuman Fong

Active 1987–2025

347
Papers
66,934
Citations
142
h-index
339
i10-index

Citations

Citations per year for Yuman Fong1939: 2 citations1987: 1 citations1988: 39 citations1989: 91 citations1990: 142 citations1991: 165 citations1992: 180 citations1993: 159 citations1994: 110 citations1995: 124 citations1996: 147 citations1997: 144 citations1998: 139 citations1999: 159 citations2000: 218 citations2001: 248 citations2002: 310 citations2003: 328 citations2004: 323 citations2005: 400 citations2006: 455 citations2007: 543 citations2008: 468 citations2009: 542 citations2010: 515 citations2011: 425 citations2012: 511 citations2013: 464 citations2014: 512 citations2015: 490 citations2016: 389 citations2017: 393 citations2018: 257 citations2019: 1,475 citations2020: 1,500 citations2021: 1,316 citations2022: 931 citations2023: 632 citations2024: 1,022 citations2025: 412 citations2026: 14 citations1940–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,866 citing papers, 28.4% of this breakdownChina: 1,725 citing papers, 10.1% of this breakdownItaly: 1,029 citing papers, 6% of this breakdownUnited Kingdom: 971 citing papers, 5.7% of this breakdownJapan: 915 citing papers, 5.3% of this breakdownGermany: 908 citing papers, 5.3% of this breakdownFrance: 831 citing papers, 4.8% of this breakdownNetherlands: 692 citing papers, 4% of this breakdownCanada: 536 citing papers, 3.1% of this breakdownSouth Korea: 436 citing papers, 2.5% of this breakdownSpain: 337 citing papers, 2% of this breakdownAustralia: 331 citing papers, 1.9% of this breakdown
0%28.4%Other 20.9%

Fields

  • Medicine76.1%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology5.1%
  • Neuroscience1.4%
  • Engineering1.1%
  • Nursing0.7%
  • Other2.5%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis10.4%
  • Cholangiocarcinoma and Gallbladder Cancer Studies7.9%
  • Pancreatic and Hepatic Oncology Research5.3%
  • Gallbladder and Bile Duct Disorders4.4%
  • Organ Transplantation Techniques and Outcomes2.5%
  • Colorectal Cancer Treatments and Studies2.2%
  • Other67.3%

Coauthors

All papers

Open in search
  1. Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer

    Authors: , , , , - Annals of Surgery 1999 cited by 3,717

  2. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors

    Authors: , , , , , , , , , , , - Science Translational Medicine 2020 cited by 262

  3. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions

    Authors: , , , , , , , , , , , , , , , - Genome Medicine 2020 cited by 342

  4. Intrahepatic Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , - Annals of Surgery 2008 cited by 884

  5. The International Position on Laparoscopic Liver Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John B. Martinie, Jean‐Nicolas Vauthey, Robert M. Goldstein, Sasan Roayaie, David Barlet, Joseph Espat, Michaël Abécassis, Myrddin Rees, Yuman Fong, Kelly M. McMasters, Christoph E. Broelsch, Ron Busuttil, Jacques Belghiti, Steven M. Strasberg, Ravi S. Chari - Annals of Surgery 2009 cited by 1,517

  6. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

    Authors: , , , , , , , - Current Problems in Surgery 2018 cited by 292

  7. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma

    Authors: , , , , , , , , - Annals of Surgery 2001 cited by 1,361

  8. Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2007 cited by 1,179

  9. International experts consensus guidelines on robotic liver resection in 2023

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - World Journal of Gastroenterology 2023 cited by 98

  10. International consensus statement on robotic hepatectomy surgery in 2018

    Authors: , , , , , , , , , , , , , , , , , , , , , - World Journal of Gastroenterology 2019 cited by 216

  11. Laparoscopic versus robotic abdominal and pelvic surgery: a systematic review of randomised controlled trials

    Authors: , , - Surgical Endoscopy 2023 cited by 62

  12. Endoneurial Macrophages Induce Perineural Invasion of Pancreatic Cancer Cells by Secretion of GDNF and Activation of RET Tyrosine Kinase Receptor

    Authors: , , , , , , , , , , - Cancer Research 2012 cited by 177

  13. Paracrine Regulation of Pancreatic Cancer Cell Invasion by Peripheral Nerves

    Authors: , , , , , , , , , - JNCI Journal of the National Cancer Institute 2010 cited by 235

  14. Fluorescent imaging for cancer therapy and cancer gene therapy

    Authors: , , , , - Molecular Therapy — Oncolytics 2021 cited by 63

  15. Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy

    Authors: , , , , , , , , , , - Scientific Reports 2019 cited by 101

  16. Development and Validation of an Explainable Machine Learning Model for Major Complications After Cytoreductive Surgery

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2022 cited by 60

  17. Gallbladder cancer (GBC): 10‐year experience at Memorial Sloan‐Kettering Cancer Centre (MSKCC)

    Authors: , , , , , , , , , - Journal of Surgical Oncology 2008 cited by 469

  18. Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds

    Authors: , , , , - Molecular Therapy — Oncolytics 2019 cited by 160

  19. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

    Authors: , , , , , , , , - 2002 cited by 1,486

  20. Improvement in Perioperative Outcome After Hepatic Resection

    Authors: , , , , , , , , - Annals of Surgery 2002 cited by 1,252

  21. The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer

    Authors: , , , , , , , - European Journal of Cancer 2017 cited by 220

  22. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

    Authors: , , , , , , , , , , , - Annals of Oncology 2009 cited by 190

  23. Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer

    Authors: , , , , , , , , , , , - Scientific Reports 2018 cited by 115

  24. TRIPOD Reporting Guidelines for Diagnostic and Prognostic Studies

    Authors: , , - JAMA Surgery 2021 cited by 58